?
  Home

 
 
-
-

In Vitro Cytotoxicity Testing

We currently have over 400 mammalian cell lines, 350 different human cancer cell lines, as well as numerous primary human cells (e.g., HEKa, HUVEC, HMVEC, NHDF, NHEK, PBMC). We can analyze the biological activity of your compound by itself or in combination with other known chemotherapeutic agents, see list below.

Please contact us with any request for cell-based toxicity testing. We can perform any non -radioactive cytotoxicity assay (e.g. The MultiTox-Glo Multiplex Cytotoxicity Assay, ApoGlow). Moreover, we can order any new cell line and custom develop your assay as requested.

The following list contains 29 anti-cancer drugs currently available for research purposes at SBH Sciences:

Adrucil - Fluorouracil (5FU)
Artesunate
Artemisinin
Avastin
Bortezomib (Valcade)
Camptothecin
Carboplatin
Cyclophosphamide (Cytoxan)
Cisplatin (data), cisplatinum or
cis- Diamminedichloroplatinum (II)(data)
Dasatinib
Doxorubicin (data)
Erlotinib (data)
Etoposide
Gefitinib (Iressa)
Gemcitabine Hydrochloride
Imatinib (Gleevec)
Irinotecan HCl
Ifosfamide
Leptomycin B
Mitomycin C (data)
Neomycin Sulfate
a-Solanine
Paclitaxel (Taxol)
Sorafenib
Staurosporine
Tamoxifen
Tomatine
Vinblastine
Vincristine

SBH Sciences collaborated with Karyopharm Therapeutics in its anti-cancer development program, evaluating over 200 cancer cell lines, to screen for a potential anti-cancer drug. Additionally, SBH Sciences and Karyopharm Therapeutics presented ten scientific abstracts together.


-
-
- - -


Discovery Research Products & Services
(508) 650-6218 | Info@SBHsciences.com
The World's Leading Provider of Cytokine Cell-Based Assays